76 related articles for article (PubMed ID: 34032247)
1. Half-sandwich organometallic Ru and Rh complexes of (N,N) donor compounds: effect of ligand methylation on solution speciation and anticancer activity.
Mészáros JP; Pape VFS; Szakács G; Németi G; Dénes M; Holczbauer T; May NV; Enyedy ÉA
Dalton Trans; 2021 Jun; 50(23):8218-8231. PubMed ID: 34032247
[TBL] [Abstract][Full Text] [Related]
2. Rhodium(III) Dihalido Complexes: The Effect of Ligand Substitution and Halido Coordination on Increasing Cancer Cell Potency.
Lord RM; Zegke M; Basri AM; Pask CM; McGowan PC
Inorg Chem; 2021 Feb; 60(3):2076-2086. PubMed ID: 33463147
[TBL] [Abstract][Full Text] [Related]
3. Mononuclear η
Kanyora AK; Omondi RO; Ongoma P; Omolo JO; Welsh A; Prince S; Gichumbi J; Mambanda A; Smith GS
J Biol Inorg Chem; 2024 Mar; 29(2):251-264. PubMed ID: 38494554
[TBL] [Abstract][Full Text] [Related]
4. Green Light-Triggered Photocatalytic Anticancer Activity of Terpyridine-Based Ru(II) Photocatalysts.
Mandal AA; Singh V; Saha S; Peters S; Sadhukhan T; Kushwaha R; Yadav AK; Mandal A; Upadhyay A; Bera A; Dutta A; Koch B; Banerjee S
Inorg Chem; 2024 Apr; 63(16):7493-7503. PubMed ID: 38578920
[TBL] [Abstract][Full Text] [Related]
5. Ru(II)-Arene Complexes of Curcumin and Bisdesmethoxycurcumin Metabolites.
Pagliaricci N; Pettinari R; Marchetti F; Tombesi A; Pagliaricci S; Cuccioloni M; Galindo A; Fadaei-Tirani F; Hadiji M; Dyson PJ
Inorg Chem; 2024 Apr; 63(17):7955-7965. PubMed ID: 38634659
[TBL] [Abstract][Full Text] [Related]
6. Striking difference in antiproliferative activity of ruthenium- and osmium-nitrosyl complexes with azole heterocycles.
Büchel GE; Gavriluta A; Novak M; Meier SM; Jakupec MA; Cuzan O; Turta C; Tommasino JB; Jeanneau E; Novitchi G; Luneau D; Arion VB
Inorg Chem; 2013 Jun; 52(11):6273-85. PubMed ID: 23659478
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium(II) arene complexes with chelating chloroquine analogue ligands: synthesis, characterization and in vitro antimalarial activity.
Glans L; Ehnbom A; de Kock C; Martínez A; Estrada J; Smith PJ; Haukka M; Sánchez-Delgado RA; Nordlander E
Dalton Trans; 2012 Mar; 41(9):2764-73. PubMed ID: 22249579
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapeutic Activities of New η
Ywaya DO; Ibrahim H; Friedrich HB; Bala MD; Soobramoney L; Daniels A; Singh M
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474456
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
Lee SY; Kim CY; Nam TG
Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303
[TBL] [Abstract][Full Text] [Related]
10. Photorelease of Pyridyl Esters in Organometallic Ru(II) Arene Complexes.
Habtemariam A; Garino C; Ruggiero E; Alonso-de Castro S; Mareque-Rivas JC; Salassa L
Molecules; 2015 Apr; 20(4):7276-91. PubMed ID: 25905605
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of 8-hydroxyquinoline-triphenylphosphine rhodium(III) complexes targeting mitophagy pathways.
Huang XQ; Wu RC; Liang JM; Zhou Z; Qin QP; Liang H
Eur J Med Chem; 2024 Jun; 272():116478. PubMed ID: 38718624
[TBL] [Abstract][Full Text] [Related]
12. Interactions of arene-Ru(II)-chloroquine complexes of known antimalarial and antitumor activity with human serum albumin (HSA) and transferrin.
Martínez A; Suárez J; Shand T; Magliozzo RS; Sánchez-Delgado RA
J Inorg Biochem; 2011 Jan; 105(1):39-45. PubMed ID: 21113330
[TBL] [Abstract][Full Text] [Related]
13. Exploration of the Pharmacophore for Cytoskeletal Targeting Ruthenium Polypyridyl Complexes.
Reardon MM; Guerrero M; Alatrash N; MacDonnell FM
ChemMedChem; 2023 Nov; 18(21):e202300347. PubMed ID: 37574460
[TBL] [Abstract][Full Text] [Related]
14. Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity.
Gatti A; Habtemariam A; Romero-Canelón I; Song JI; Heer B; Clarkson GJ; Rogolino D; Sadler PJ; Carcelli M
Organometallics; 2018 Mar; 37(6):891-899. PubMed ID: 29681675
[TBL] [Abstract][Full Text] [Related]
15. Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity.
Wang F; Habtemariam A; van der Geer EP; Fernández R; Melchart M; Deeth RJ; Aird R; Guichard S; Fabbiani FP; Lozano-Casal P; Oswald ID; Jodrell DI; Parsons S; Sadler PJ
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18269-74. PubMed ID: 16352726
[TBL] [Abstract][Full Text] [Related]
16. Organometallic
Betanzos-Lara S; Habtemariam A; Clarkson GJ; Sadler PJ
Eur J Inorg Chem; 2011 Jul; 2011(21):3257-3264. PubMed ID: 23956682
[TBL] [Abstract][Full Text] [Related]
17. Anticancer Activity of Half-Sandwich Ru, Rh and Ir Complexes with Chrysin Derived Ligands: Strong Effect of the Side Chain in the Ligand and Influence of the Metal.
Rubio AR; González R; Busto N; Vaquero M; Iglesias AL; Jalón FA; Espino G; Rodríguez AM; García B; Manzano BR
Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683834
[TBL] [Abstract][Full Text] [Related]
18. Osmium-arene complexes with high potency towards Mycobacterium tuberculosis.
Coverdale JPC; Guy CS; Bridgewater HE; Needham RJ; Fullam E; Sadler PJ
Metallomics; 2021 Apr; 13(4):. PubMed ID: 33693931
[TBL] [Abstract][Full Text] [Related]
19. Dissimilar effect of organometallic ruthenium complexes on the viability of MDR and non-MDR experimental models.
Opačak S; Kovač MP; Landais C; Debeljak Ž; Golding TM; Smith GS; Brozovic A; Kirin SI
J Inorg Biochem; 2024 Aug; 257():112614. PubMed ID: 38781850
[TBL] [Abstract][Full Text] [Related]
20. Modulating Excited State Properties and Ligand Ejection Kinetics in Ruthenium Polypyridyl Complexes Designed to Mimic Photochemotherapeutics.
Robinette FN; Valentine NP; Sehler KM; Medeck AM; Reynolds KE; Lane SN; Price AN; Cavanaugh IG; Shell SM; Ashford DL
Inorg Chem; 2024 May; 63(18):8426-8439. PubMed ID: 38662617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
